Monotonous- but a good job with a good company - Avis employé Pharmaceuticals Sales Representative Merck

4,0
10 mai 2014
Recommande
Approbation du PDG
Perspective commerciale

Avantages

I was proud to say I worked for Merck- good solid company with a good reputation among doctors. At the time we had a robust pipeline and were preparing to launch several new products that we developed- not bought like some other pharmaceutical companies. Decent pay- with nice compensation package- car, sales "points" which you could buy products- nice 401K plan with company match etc.

Inconvénients

Way too many of us- was really difficult to stand out. Too much comparison to other territories and areas throughout the nation- like comparing apples to oranges. It was hard to stand out with all the regulations and rules. I was like a square peg in a round hole- drone like. The job became very monotonous and I quickly realized that pharmaceutical sales was NOTHING like it was in the old days. Obviously- instability. They flooded the market with a ton of us- then let us all go- helping to contribute to the economy woes.

Découvrez plus d’avis sur Merck

5,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent company to work with.

Inconvénients

No cons encountered so far

4,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Inconvénients

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Voir les avis par: Utile|Évaluation|Date|Tout